DVA241115C130000
- 15.33
- 0.000.00%
DaVita Newsroom
DaVita Inc. to Participate in UBS Global Healthcare Conference 2024
Truist Financial Maintains DaVita(DVA.US) With Hold Rating, Announces Target Price $170
Barclays Maintains DaVita(DVA.US) With Hold Rating, Maintains Target Price $164
TD Cowen Maintains DaVita(DVA.US) With Hold Rating, Maintains Target Price $150
DaVita Is Maintained at Equal-Weight by Barclays
DaVita Analyst Ratings
UBS Adjusts Price Target on DaVita to $186 From $175, Maintains Buy Rating
US Stock Golden | Surged 240% within the year! The social platform Reddit soared over 40% after its performance, hitting a historical high; multiple bullish factors are stimulating! The US student loan giant SoFi surged over 40% in October.
1.4 billion acquisition finalized! Pharmaceutical giant abbvie acquires Alzheimer's drug company Aliada, hitting a new high after earnings last night.
Barclays Maintains DaVita(DVA.US) With Hold Rating, Raises Target Price to $164
Why DaVita Stock Withered on Wednesday
Trending Stocks Today | Tharimmune Surges 110.83%
October 30th - US stocks trending in regular trading hours.Gainers: $Tharimmune(THAR.US)$ shoots up 110.83% to $4.28 with a turnover of $281.53 million. $Vast Renewables(VSTE.US)$ soars 95.04% to $1.9
DaVita Stock Declines After Q3 Earnings Miss Estimates, Margins Up
DaVita Down Over 8%, on Pace for Largest Percent Decrease in Over a Year -- Data Talk
Truist Financial Maintains DaVita(DVA.US) With Hold Rating
Express News | DaVita Inc : Deutsche Bank Raises Target Price to $165 From $145
BofA Securities Initiates DaVita(DVA.US) With Sell Rating, Announces Target Price $145
Decoding DaVita Inc (DVA): A Strategic SWOT Insight
DaVita Inc. (DVA) Q3 2024 Earnings Call Transcript Summary
DaVita Inc. (DVA) Q3 2024 Earnings Call Transcript
DaVita Q3 Adjusted EPS Decreases, Revenue Rises; 2024 EPS Outlook Reiterated